N. Kurmasheva

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen

J. Diallo, Stephen Boulton, S. Paludan, 2022, Molecular Therapy.

c-Myc plays a key role in IFN-γ-induced persistence of Chlamydia trachomatis

A. Schulze, T. Rudel, W. Schmitz, 2021, bioRxiv.

The Potential Virulence Factors of Providencia stuartii: Motility, Adherence, and Invasion

M. Sharipova, A. Mardanova, N. Kurmasheva, 2018, BioMed research international.

VPS34-dependent control of apical membrane function of proximal tubule cells and nutrient recovery by the kidney

Anja M. Billing, Markus M. Rinschen, G. Siuzdak, 2022, Science Signaling.

Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern

J. Diallo, J. van Grevenynghe, J. Hiscott, 2021, ACS infectious diseases.

Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development

Stephen Boulton, J. Bell, R. Parks, 2023, Journal of Biological Chemistry.